IL2 and tuberculosis: Adjunctive ZOL/IL-2 administrations after MDR-TB infection led to lower MDR-TB bacterial burdens in lungs than TB drugs alone, IL-2 alone, or saline controls, and resulted in body weight gains at weeks 17–21